Literature DB >> 32188681

Prevalence and clinical features of systemic diseases in Chinese patients with uveitis.

Peizeng Yang1, Zhenyu Zhong2, Liping Du3, Fuzhen Li3, Zhijun Chen2, Ying Zhu2, Wanyun Zhang2, Fanfan Huang2, Xingsheng Ye2, Guannan Su2, Aize Kijlstra4.   

Abstract

PURPOSE: Systemic diseases are frequently associated with uveitis but are often not recognised by clinicians. An estimate of the prevalence in a large-scale uveitis population is essential for understanding the epidemiological profile and may be helpful for clinical practice.
DESIGN: A nationwide survey.
METHODS: Data were obtained from a national database which included the registration of uveitis cases from 23 provinces, 5 autonomous regions and 4 municipalities across mainland China. The primary outcome was identification of a systemic disease associated with uveitis.
RESULTS: From April 2008 through August 2018, 15 373 uveitis patients were included in the study. Males accounted for 52.9%, and the mean (SD) age of uveitis onset was 35.4 (15.9) years. After standardisation for age, the prevalence of systemic disease among patients with uveitis was 30.8% (95% CI, 30.1% to 31.6%). Vogt-Koyanagi-Harada disease (VKH; age-standardised prevalence, 12.7%; 95% CI, 12.1% to 13.2%), Behçet's disease (BD; 8.7%; 95% CI, 8.3% to 9.2%), ankylosing spondylitis (AS; 5.0%; 95% CI, 4.6% to 5.3%) and juvenile idiopathic arthritis (JIA; 1.2%; 95% CI, 1.0% to 1.3%) were the most common entities among 36 different forms of systemic diseases identified. The prevalence was significantly higher in males (37.0%; 95% CI, 36.0% to 38.1%) than in females (23.6%; 95% CI, 22.6% to 24.6%), and also higher in bilateral uveitis patients (41.2%; 95% CI, 40.2% to 42.2%) compared with unilateral cases (14.3%; 95% CI, 13.4% to 15.2%), and was highest in panuveitis (59.5%; 95% CI, 58.2% to 60.8%).
CONCLUSION: Approximately one third of uveitis patients in this nationwide survey have an associated systemic disease, whereby VKH, BD, AS and JIA are the most frequent entities seen in China. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; inflammation

Year:  2020        PMID: 32188681     DOI: 10.1136/bjophthalmol-2020-315960

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Clinical Features of Japanese Patients with Ocular Inflammation and Their Surgical Procedures Over the Course of 20 Years.

Authors:  Nanae Takai; Takatoshi Kobayashi; Teruyo Kida; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2020-09-24

2.  Metabolomic Analysis of Aqueous Humor Identifies Aberrant Amino Acid and Fatty Acid Metabolism in Vogt-Koyanagi-Harada and Behcet's Disease.

Authors:  Jing Xu; Guannan Su; Xinyue Huang; Rui Chang; Zhijun Chen; Zi Ye; Qingfeng Cao; Aize Kijlstra; Peizeng Yang
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

3.  Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease.

Authors:  Jia Shu; Guannan Su; Jun Zhang; Zhangluxi Liu; Rui Chang; Qingfeng Wang; Peizeng Yang
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 4.  Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad.

Authors:  Yongtong Ge; Dalei Cheng; Qingzhi Jia; Huabao Xiong; Junfeng Zhang
Journal:  Immune Netw       Date:  2021-05-26       Impact factor: 6.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.